Partha Protim Sarker

Mr. Partha Protim Sarker

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Md Abdul HannanMd Abdul Hannan
Md Abdul Hannan
Md Ataur RahmanMd Ataur Rahman
Md Ataur Rahman
Abdullah Al Mamun SohagAbdullah Al Mamun Sohag
Abdullah Al Mamun Sohag
Md Jamal UddinMd Jamal Uddin
Md Jamal Uddin
Raju DashRaju Dash
Raju Dash
Bonglee KimBonglee Kim
Bonglee Kim
Mounting evidence support the potential benefits of functional foods or nutraceuticals for human health and diseases. Black cumin (Nigella sativa L.), a highly valued nutraceutical herb with a wide array of health benefits, has attracted growing interest from health-conscious individuals, the scientific community, and pharmaceutical industries. The pleiotropic pharmacological effects of black cumin, and its main bioactive component thymoquinone (TQ), have been manifested by their ability to attenuate oxidative stress and inflammation, and to promote immunity, cell survival, and energy metabolism, which underlie diverse health benefits, including protection against metabolic, cardiovascular, digestive, hepatic, renal, respiratory, reproductive, and neurological disorders, cancer, and so on. Furthermore, black cumin acts as an antidote, mitigating various toxicities and drug-induced side effects. Despite significant advances in pharmacological benefits, this miracle herb and its active components are still far from their clinical application. This review begins with highlighting the research trends in black cumin and revisiting phytochemical profiles. Subsequently, pharmacological attributes and health benefits of black cumin and TQ are critically reviewed. We overview molecular pharmacology to gain insight into the underlying mechanism of health benefits. Issues related to pharmacokinetic herb–drug interactions, drug delivery, and safety are also addressed. Identifying knowledge gaps, our current effort will direct future research to advance potential applications of black cumin and TQ in health and diseases.

Verified
Journal Article
Open access
PDF file
Md Abdul HannanMd Abdul Hannan
Md Abdul Hannan
Md. Sarwar ZahanMd. Sarwar Zahan
Md. Sarwar Zahan
PSPartha Protim Sarker
Partha Protim Sarker
AMAkhi Moni
Akhi Moni
Hunjoo HaHunjoo Ha
Hunjoo Ha
Md Jamal UddinMd Jamal Uddin
Md Jamal Uddin
The prevalence of chronic kidney disease (CKD) is increasing worldwide, and a close association between acute kidney injury (AKI) and CKD has recently been identified. Black cumin (Nigella sativa) has been shown to be effective in treating various kidney diseases. Accumulating evidence shows that black cumin and its vital compound, thymoquinone (TQ), can protect against kidney injury caused by various xenobiotics, namely chemotherapeutic agents, heavy metals, pesticides, and other environmental chemicals. Black cumin can also protect the kidneys from ischemic shock. The mechanisms underlying the kidney protective potential of black cumin and TQ include antioxidation, anti-inflammation, anti-apoptosis, and antifibrosis which are manifested in their regulatory role in the antioxidant defense system, NF-κB signaling, caspase pathways, and TGF-β signaling. In clinical trials, black seed oil was shown to normalize blood and urine parameters and improve disease outcomes in advanced CKD patients. While black cumin and its products have shown promising kidney protective effects, information on nanoparticle-guided targeted delivery into kidney is still lacking. Moreover, the clinical evidence on this natural product is not sufficient to recommend it to CKD patients. This review provides insightful information on the pharmacological benefits of black cumin and TQ against kidney damage.

2 September 2024 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
MOMicaela Oliveira
Micaela Oliveira
PSPartha Protim Sarker
Partha Protim Sarker
ISIlya Skovorodkin
Ilya Skovorodkin
Ali KalantarifardAli Kalantarifard
Ali Kalantarifard
THTugce Haskavuk
Tugce Haskavuk
IRIrina Raykhel
Irina Raykhel
The new lab-on-a-chip design allows organoids of different origin to be cultured and vascularized on CAM and to be transferred them in vitro conditions.